Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-11-14
1996-07-30
Dentz, Bernard
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
536 173, C07D491147, C07D49122
Patent
active
055413277
ABSTRACT:
Substituted analogues of camptothecin possessing cytotoxic activity towards cancer cells, of the general structure: ##STR1## wherein E is H, CO.sub.2 R, CONH.sub.2, CONHR, CONR.sub.2, acyl, or CN; X is H, OH, or OR; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently the same or different and are H, or a linear or branched chain alkyl, alkylaryl, or hydroxyalkyl group, or an aryl group; R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 are independently the same or different and are H, or a linear or branched chain alkyl, alkylaryl, alkoxy, hydroxyalkyl, or aminoalkoxy group, or an aryl or aryloxy group, or a C-glycal, or CO.sub.2 R, nitro, cyano, Cl, F, Br, I, SR.sup.10, NR.sup.11 R.sup.12, OR.sup.13 ; R is H, or a linear or branched chain alkyl, alkylaryl, or hydroxyalkyl group, or an aryl group; R.sup.10, R.sup.11 and R.sup.12 are independently the same or different and are H, or a linear or branched chain alkyl, alkylaryl, hydroxyalkyl, or acyl group, or an aryl group; R.sup.13 is glycosyl; n is 0 or 1; with the proviso that when R.sup.1 is ethyl, and n is 0, E, R.sup.2, R.sup.3, and R.sup.4 are not all H. Intermediate compounds leading to the camptothecin analogues comprise substituted tricyclic compounds which consist of rings C, D, and E fused together. Methods for preparing the analogues involve condensation of such intermediates with variably substituted protected .alpha.-aminobenzaldehydes.
REFERENCES:
patent: 3894029 (1975-07-01), Winterfeldt et al.
patent: 4031098 (1977-06-01), Sugasawa
patent: 4399282 (1983-08-01), Miyasaka et al.
patent: 4473692 (1984-09-01), Miyasaka et al.
patent: 4513138 (1985-04-01), Miyasaka et al.
patent: 4545880 (1985-10-01), Miyasaka et al.
patent: 4604463 (1986-08-01), Miyasaka et al.
patent: 4894456 (1990-01-01), Wall et al.
patent: 4914205 (1990-04-01), Sawada et al.
patent: 4939255 (1990-07-01), Tagawa et al.
patent: 4943579 (1990-07-01), Vishnuvajjala et al.
patent: 4981968 (1991-01-01), Wall et al.
patent: 5004758 (1991-04-01), Boehm et al.
patent: 5049668 (1991-09-01), Wall et al.
patent: 5061795 (1991-10-01), Tagawa et al.
patent: 5061800 (1991-10-01), Yaegashi et al.
patent: 5106742 (1992-04-01), Wall et al.
patent: 5112526 (1992-06-01), Wall et al.
Tang et al., J.A.C.S. vol. 97(1), pp. 159-167 (1975).
Danishefsky, S., and Etheredge, S. J., J. Org. Chem., 39:3430-3432 (1974); U.S.A..
Giovanella, B. C. , et al., Science, 246:1046-1048 (1989); U.S.A..
Hsiang, Y.-H., et al., J. Biol. Chem., 260:14873-14878 (1985); U.S.A..
Hsiang, Y.-H., and Liu, L. F., Cancer Research, 48:1722-1726 (1988); U.S.A..
T. Kunimoto, et al., Cancer Research, 47:5944-5947 (1987); U.S.A.
Bornmann William G.
Coburn Craig A.
Danishefsky Samuel J.
Shen Wang
Dentz Bernard
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Preparation of camptothecin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of camptothecin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of camptothecin analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659974